Skip to main content
. 2018 Oct 8;28(11):1090–1102. doi: 10.1038/s41422-018-0086-7

Fig. 7.

Fig. 7

PKM2 is over-expressed in cancer where it unites cancer glycolytic metabolism with DNA repair to drive treatment resistance. PKM2 is frequently overexpressed in cancer cells where cytosolic PKM2 reprograms glucose metabolism (Warburg effect), while nuclear PKM2 has additional oncogenic function as a transcriptional coactivator (black arrows). Our data uncovered a novel nuclear function of PKM2 through which it directly regulates DNA DSB repair and resistance to genotoxic damage (red arrows). ATM, activated by DNA DSBs, phosphorylates nuclear PKM2 at T328, resulting in nuclear retention and accumulation of PKM2. pT328-PKM2 interacts with CtIP and phosphorylates CtIP on T126 to increase its function in HR repair, resulting in increased DSB repair efficiency and resistance to genotoxic treatments